< 1 minute read
Sep. 18, 2021
Remogliflozin Etabonate: SGLT1-Sparing Oral SGLT2 Inhibitor Prodrug
remogliflozin etabonate
SGLT1-sparing oral SGLT2 inhibitor prodrug launched in India for diabetes, 100 mg BID from mouse urine drug metabolite and opt. Bioorg. Med. Chem., Jan. 22, 2021 Kissei Pharma / Toho University, JP